We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 990

Disputed Federal Regulatory Duty Allows Federal Question Removal
  • Reed Smith LLP
  • USA
  • March 23 2017

As we’ve mentioned before, we watch state-law litigation over genetically-modified organisms (“GMOs”) because they tend to produce interesting


All Things “Considered”: Plaintiffs’ Experts Ordered To Produce Patient Records
  • Reed Smith LLP
  • USA
  • March 21 2017

“The facts and data considered by the witness . . . .” That is what expert witnesses must disclose to the other side after forming their opinions


What If We Win? Off-Label Promotion & Product Liability
  • Reed Smith LLP
  • USA
  • March 20 2017

Since the nomination of Dr. Scott Gottlieb to head the FDA, we’ve seen quite a few references to his opposition to the current FDA prohibition


Another Court Tackles Prescription Drug Design Defect
  • Reed Smith LLP
  • USA
  • March 17 2017

If you have been following along for a while, then you have surely run across our posts making some combination of the following points: 1) design


There’ll Always Be Posner: Reversal of Class Certification in the Blink of an Eye
  • Reed Smith LLP
  • USA
  • March 15 2017

We’ve seen it before. The Southern District of Illinois will certify class actions with no real cause of action and no real damages. While not as bad


Hip Implant MDL Denies Summary Judgment on Claims of Plaintiffs Who Failed to Preserve Explanted Devices
  • Reed Smith LLP
  • USA
  • March 13 2017

Regular readers of this blog know that we have a pretty jaded view of many MDLs. Obviously consolidation makes sense, at least on paper, in terms of


Guest Post - The Matrix Preempted
  • Reed Smith LLP
  • USA
  • March 10 2017

Today’s guest post is by Aggie Lee of Tucker Ellis, about a PMA preemption win that she briefed in California. The medical device is a hemostatic


JPML Refuses MDL for Proton Pump Inhibitor Kidney Injury Cases
  • Reed Smith LLP
  • USA
  • March 7 2017

A Multidistrict Litigation (MDL) can be a sound way of managing a mass tort. Efficiencies are available (e.g., deposing company witnesses only once


Southern District of Indiana Excludes Plaintiffs’ Experts in Hernia Mesh Case
  • Reed Smith LLP
  • USA
  • March 2 2017

We loved La La Land. We were enchanted by the colors and the music and the dancing. We were transported by the dreams-come-true and saddened by the


Life Sciences: product regulation and liability in France
  • Reed Smith LLP
  • France, Global
  • February 28 2017

A structured guide to product regulation and liability laws in France